Entero Healthcare Solutions Ltd. Total Liabilities
Entero Healthcare Solutions Ltd. total liabilities. Based on the latest financial reports, Entero Healthcare Solutions Ltd. (ENTERO) has total liabilities worth Rs18.48 Billion INR (≈ $199.82 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Entero Healthcare Solutions Ltd. liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Entero Healthcare Solutions Ltd. (2019–2025)
Total liabilities of Entero Healthcare Solutions Ltd. from 2019 to 2025. This chart illustrates how Entero Healthcare Solutions Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check Entero Healthcare Solutions Ltd. (ENTERO) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Entero Healthcare Solutions Ltd. Competitors by Total Liabilities
The table below lists competitors of Entero Healthcare Solutions Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Orrstown Financial Services Inc
NASDAQ:ORRF
|
USA | $4.95 Billion |
|
PAR Technology Corporation
NYSE:PAR
|
USA | $556.10 Million |
|
Amtran Technology Co Ltd
TW:2489
|
Taiwan | NT$9.00 Billion |
|
Tangrenshen Group Co Ltd
SHE:002567
|
China | CN¥11.42 Billion |
|
Tianjin Silvery Dragon
SHG:603969
|
China | CN¥1.82 Billion |
|
Suzhou Shihua New Material Technology Co Ltd
SHG:688093
|
China | CN¥119.49 Million |
|
Dan Hotels
TA:DANH
|
Israel | ILA1.30 Billion |
|
Atal SA
WAR:1AT
|
Poland | zł3.25 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Entero Healthcare Solutions Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Entero Healthcare Solutions Ltd..
Liquidity & Leverage Metrics
Entero Healthcare Solutions Ltd. Total Liabilities Ratios Explained
Entero Healthcare Solutions Ltd. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Entero Healthcare Solutions Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Entero Healthcare Solutions Ltd. (2019–2025)
The table below shows the annual total liabilities of Entero Healthcare Solutions Ltd. from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | Rs18.48 Billion ≈ $199.82 Million |
+98.22% |
| 2024-09-30 | Rs9.32 Billion ≈ $100.81 Million |
+32.49% |
| 2023-09-30 | Rs7.04 Billion ≈ $76.09 Million |
-9.37% |
| 2022-09-30 | Rs7.76 Billion ≈ $83.96 Million |
+37.95% |
| 2021-09-30 | Rs5.63 Billion ≈ $60.86 Million |
+62.31% |
| 2020-09-30 | Rs3.47 Billion ≈ $37.50 Million |
+6.68% |
| 2019-09-30 | Rs3.25 Billion ≈ $35.15 Million |
-- |
About Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also p… Read more